IART - Integra LifeSciences Holdings Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue1,188,236992,075882,734
Cost of Revenue435,511349,089326,542
Gross Profit752,725642,986556,192
Operating Expenses
Research Development63,45558,15550,895
Selling General and Administrative624,096455,629415,757
Non Recurring---
Others20,37013,8629,953
Total Operating Expenses---
Operating Income or Loss44,804115,34079,587
Income from Continuing Operations
Total Other Income/Expenses Net1,6008694,618
Earnings Before Interest and Taxes46,404116,20984,205
Interest Expense35,01925,80323,534
Income Before Tax11,38590,40660,671
Income Tax Expense-53,35815,84253,820
Minority Interest---
Net Income From Continuing Ops64,74374,5646,851
Non-recurring Events
Discontinued Operations---10,370
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income64,74374,564-3,519
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares64,74374,564-3,519